TG Therapeutics Investigational Trial Site is a clinical research site located in Ann Arbor, Michigan, United States 48197.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
TG Therapeutics Investigational Trial Site has participated in 6 clinical trials with 2 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, B-cell Mediated Autoimmune Disorders, Small Lymphocytic Lymphoma.
Sponsors: TG Therapeutics, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Ann Arbor
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
TG Therapeutics Investigational Trial Site has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
TG Therapeutics Investigational Trial Site has 6 clinical trials on record, with 2 currently active. Their work covers Chronic Lymphocytic Leukemia, B-cell Mediated Autoimmune Disorders, Small Lymphocytic Lymphoma.
TG Therapeutics Investigational Trial Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.